Youre not renting a result
Recent cardiovascular outcomes trials have shifted how clinicians think about therapy selection, Read More GLP-1 Resistance in Diabetes Care: Should Poor Response Change Treatment Strategy
Psychopharmacology (Berl) 130 : 269275 Meloni D, Gambarana C, De Montis MG, Dal Pr P, Taddei I, Tagliamonte A
Glucose-6-Phosphate Dehydrogenase Deficiency (G6PDD) - G6PD is a metabolic enzyme required in the pentose phosphate pathway and is particularly important in red blood cell metabolism
Another possible contributing mechanism is maladaptive neuroplasticity, in which neuronal pathways adapt and conform pathologically to changes in auditory system nerve signaling
those in the intervention group were 7.4 times more likely to respond in this small study (126)